TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
TCRX

Tscan Therapeutics Inc

Healthcare · Biotechnology

0.349$ -4.1% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow TCRX
Line item 2019 2020 2021 2022 2023 2024 2025
– – – – – – –
– +137.0% +170.6% +54.4% +4.4% -23.4% -30.2%
– +114.6% +388.5% +80.9% +14.4% +83.4% +22.6%
– +62.6% +386.7% +80.9% – – –
– +7,042.8% -127.6% – – -71.3% -459.7%
– +239.9% +134.6% -57.5% -25.5% +21.6% +15.2%
– +239.9% +134.6% -57.5% +1,338.1% -13.4% –
– – – – – – –
– – – -99.8% – – –
– +0.0% +0.0% -1.1% -100.0% – -100.0%
– -99.2% +65,756.9% -84.5% +361.4% +54.1% -100.2%
– -133.1% – -131.6% – +240.2% -158.0%
– – – – – – –

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?